Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12075733rdf:typepubmed:Citationlld:pubmed
pubmed-article:12075733lifeskim:mentionsumls-concept:C0003392lld:lifeskim
pubmed-article:12075733lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:12075733lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:12075733lifeskim:mentionsumls-concept:C0732165lld:lifeskim
pubmed-article:12075733pubmed:issue5lld:pubmed
pubmed-article:12075733pubmed:dateCreated2002-6-21lld:pubmed
pubmed-article:12075733pubmed:abstractTextSomatostatin (SST) analogues represent a novel approach for the treatment of certain cancers. The objective of this article is to summarise the current knowledge on SST analogues in the treatment of cancer patients.lld:pubmed
pubmed-article:12075733pubmed:languageenglld:pubmed
pubmed-article:12075733pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12075733pubmed:citationSubsetIMlld:pubmed
pubmed-article:12075733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12075733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12075733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12075733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12075733pubmed:statusMEDLINElld:pubmed
pubmed-article:12075733pubmed:monthMaylld:pubmed
pubmed-article:12075733pubmed:issn0923-7534lld:pubmed
pubmed-article:12075733pubmed:authorpubmed-author:RadererMMlld:pubmed
pubmed-article:12075733pubmed:authorpubmed-author:HejnaMMlld:pubmed
pubmed-article:12075733pubmed:authorpubmed-author:SchmidingerMMlld:pubmed
pubmed-article:12075733pubmed:issnTypePrintlld:pubmed
pubmed-article:12075733pubmed:volume13lld:pubmed
pubmed-article:12075733pubmed:ownerNLMlld:pubmed
pubmed-article:12075733pubmed:authorsCompleteYlld:pubmed
pubmed-article:12075733pubmed:pagination653-68lld:pubmed
pubmed-article:12075733pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:12075733pubmed:meshHeadingpubmed-meshheading:12075733...lld:pubmed
pubmed-article:12075733pubmed:meshHeadingpubmed-meshheading:12075733...lld:pubmed
pubmed-article:12075733pubmed:meshHeadingpubmed-meshheading:12075733...lld:pubmed
pubmed-article:12075733pubmed:meshHeadingpubmed-meshheading:12075733...lld:pubmed
pubmed-article:12075733pubmed:meshHeadingpubmed-meshheading:12075733...lld:pubmed
pubmed-article:12075733pubmed:meshHeadingpubmed-meshheading:12075733...lld:pubmed
pubmed-article:12075733pubmed:meshHeadingpubmed-meshheading:12075733...lld:pubmed
pubmed-article:12075733pubmed:meshHeadingpubmed-meshheading:12075733...lld:pubmed
pubmed-article:12075733pubmed:meshHeadingpubmed-meshheading:12075733...lld:pubmed
pubmed-article:12075733pubmed:meshHeadingpubmed-meshheading:12075733...lld:pubmed
pubmed-article:12075733pubmed:meshHeadingpubmed-meshheading:12075733...lld:pubmed
pubmed-article:12075733pubmed:meshHeadingpubmed-meshheading:12075733...lld:pubmed
pubmed-article:12075733pubmed:year2002lld:pubmed
pubmed-article:12075733pubmed:articleTitleThe clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?lld:pubmed
pubmed-article:12075733pubmed:affiliationDepartment of Internal Medicine I, University Hospital of Vienna, Austria. michael.hejna@akh-wien.ac.atlld:pubmed
pubmed-article:12075733pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12075733pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12075733lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12075733lld:pubmed